Aprepitant Capsules and Lidocaine Cream (Sandoz) - Drug Failure (2023)
Hazard assessment based on recall description.
This AI-generated summary is provided for general informational purposes only and is derived from publicly available recall notices. It supplements but does not replace official agency classifications or safety instructions.
Check Your Product
According to the U.S. Consumer Product Safety Commission (CPSC)
Product
Aprepitant capsules and Lidocaine and Prilocaine cream
Brand
Sandoz Inc., of Princeton, New Jersey (Lidocaine and Prilocaine cream)
Lot Codes / Batch Numbers
Not specified in CPSC notice. Check official source for details.
Product Images
Source: U.S. Consumer Product Safety Commission
Sandoz Inc., of Princeton, New Jersey (Lidocaine and Prilocaine cream) is recalling Aprepitant capsules and Lidocaine and Prilocaine cream. The hazard is: The recalled prescription drugs and products that contain lidocaine must be in child resistant packa. Based on CPSC recall notice.
Summary derived from CPSC notice
The following details were not provided by CPSC: UPC codes.
Reason for Recall
As stated by CPSC
This recall involves prescription drugs Aprepitant 125 mg capsules sold in cartons containing one blister card of 6 capsules and 5 gram tubes of Lidocaine and Prilocaine cream sold in cartons containing 5 tubes and packed with or without 12 dressings. The Aprepitant capsules are in a non-child resistant blister card packaged in a carton that has the name "Sandoz," the name of the medication, dosage, NDC number, lot number, and expiration date on the carton and on the blister cards. The warnings "This unit-dose packaging is not child-resistant" and "For institutional use only" are listed on the carton. The Lidocaine and Prilocaine cream is packaged in a 5 gram tube with a continuous thread white closure. The name "fougera®," the name of the medication, dosage and NDC number are printed on the carton and tube and the expiration date and lot number are printed on the carton and stamped on the crimp of the tube. The warning "FOR HOSPITAL USE ONLY" is printed on the carton and the tube. Product Description NDC Number Lot Number Expiration Date Aprepitant Capsules 125 mg 0781-2323-68 Carton of 1 Blister Pack of 6 capsules 0781-2323-06 Blister Pack LK3209 LC6454 04/2024 12/2023 Lidocaine and Prilocaine 2.5%/2.5% Cream 5 gram Tubes 0168-0357-56 Carton of 5 tubes and 12 dressings 0168-0357-55 Carton of 5 tubes 0168-0357-05 Tube LA2782 LA2784 LV0667 LX5350 MA1640 MB3205 LA2785 LR9041 MB3209 03/2023 03/2023 02/2024 03/2024 03/2024 04/2024 03/2023 11/2023 04/2024
Reported concern (CPSC)
The recalled prescription drugs and products that contain lidocaine must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging of the products is not child resistant, posing a risk of poisoning if the contents are swallowed by young children.
Recommended Action
Per CPSC guidance
Consumers should immediately secure the medications out of the sight and reach of children and contact Sandoz for a free child resistant pouch to store the products. Once the medication is secured, consumers can continue to use the medication as directed.
Verify this information on the official source
This page aggregates publicly available data. Always confirm recall details directly with the U.S. Consumer Product Safety Commission (CPSC) before taking action.
View official CPSC recall noticePage updated: Jan 10, 2026
Important Notice
This page displays information sourced from the U.S. Consumer Product Safety Commission (CPSC). IsMyProductRecalled.com aggregates public data for convenience and does not issue recalls. We are not affiliated with any government agency. Always verify recall information with the official source before taking action. This is not medical or legal advice.